Tekla Life Sciences Stock Performance
| HQL Stock | USD 17.17 0.01 0.06% |
Tekla Life has a performance score of 10 on a scale of 0 to 100. The entity has a beta of 0.66, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Tekla Life's returns are expected to increase less than the market. However, during the bear market, the loss of holding Tekla Life is expected to be smaller as well. Tekla Life Sciences right now has a risk of 1.29%. Please validate Tekla Life downside variance, and the relationship between the sortino ratio and accumulation distribution , to decide if Tekla Life will be following its existing price patterns.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Tekla Life Sciences are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite quite unfluctuating basic indicators, Tekla Life may actually be approaching a critical reversion point that can send shares even higher in March 2026. ...more
Actual Historical Performance (%)
One Day Return 0.0583 | Five Day Return 0.7 | Year To Date Return 2.39 | Ten Year Return (2.66) | All Time Return 14.47 |
Forward Dividend Yield 0.1061 | Payout Ratio | Forward Dividend Rate 1.82 | Dividend Date 2018-12-31 | Ex Dividend Date 2025-11-21 |
1 | abrdn Life Sciences Investors To Go Ex-Dividend on November 21st | 11/13/2025 |
2 | Insider Trading | 12/09/2025 |
3 | Acquisition by Pittard Christian of 7923 shares of Tekla Life at 16.8818 subject to Rule 16b-3 | 12/16/2025 |
4 | Acquisition by Saba Capital Management, L.p. of 26083 shares of Tekla Life at 13.76 subject to Rule 16b-3 | 12/18/2025 |
| Tekla Life dividend paid on 12th of January 2026 | 01/12/2026 |
5 | Disposition of 700 shares by Saba Capital Management, L.p. of Tekla Life at 14.13 subject to Rule 16b-3 | 01/28/2026 |
6 | Acquisition by Reit Todd of 1000 shares of Tekla Life at 13.798 subject to Rule 16b-3 | 02/02/2026 |
Tekla Life Relative Risk vs. Return Landscape
If you would invest 1,558 in Tekla Life Sciences on November 6, 2025 and sell it today you would earn a total of 159.00 from holding Tekla Life Sciences or generate 10.21% return on investment over 90 days. Tekla Life Sciences is generating 0.1676% of daily returns assuming volatility of 1.294% on return distribution over 90 days investment horizon. In other words, 11% of stocks are less volatile than Tekla, and above 97% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Tekla Life Target Price Odds to finish over Current Price
The tendency of Tekla Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 17.17 | 90 days | 17.17 | about 24.54 |
Based on a normal probability distribution, the odds of Tekla Life to move above the current price in 90 days from now is about 24.54 (This Tekla Life Sciences probability density function shows the probability of Tekla Stock to fall within a particular range of prices over 90 days) .
Tekla Life Price Density |
| Price |
Predictive Modules for Tekla Life
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Tekla Life Sciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Tekla Life Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Tekla Life is not an exception. The market had few large corrections towards the Tekla Life's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Tekla Life Sciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Tekla Life within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.01 | |
β | Beta against Dow Jones | 0.66 | |
σ | Overall volatility | 0.45 | |
Ir | Information ratio | -0.02 |
Tekla Life Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Tekla Life for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Tekla Life Sciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Tekla Life Sciences has a strong financial position based on the latest SEC filings | |
| On 12th of January 2026 Tekla Life paid $ 0.5 per share dividend to its current shareholders | |
| Latest headline from MacroaxisInsider: Acquisition by Reit Todd of 1000 shares of Tekla Life at 13.798 subject to Rule 16b-3 |
Tekla Life Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Tekla Stock often depends not only on the future outlook of the current and potential Tekla Life's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Tekla Life's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 28.9 M | |
| Cash And Short Term Investments | 75.5 K |
Tekla Life Fundamentals Growth
Tekla Stock prices reflect investors' perceptions of the future prospects and financial health of Tekla Life, and Tekla Life fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Tekla Stock performance.
| Return On Equity | 0.18 | ||||
| Return On Asset | -0.0043 | ||||
| Profit Margin | 44.16 % | ||||
| Operating Margin | (3.47) % | ||||
| Current Valuation | 507.84 M | ||||
| Shares Outstanding | 29.6 M | ||||
| Price To Earning | 2.84 X | ||||
| Price To Book | 0.98 X | ||||
| Price To Sales | 262.03 X | ||||
| Revenue | 86.39 M | ||||
| Gross Profit | 1.94 M | ||||
| EBITDA | 85.59 M | ||||
| Net Income | 85.59 M | ||||
| Cash And Equivalents | 292.4 K | ||||
| Cash Per Share | 0.01 X | ||||
| Total Debt | 1.73 M | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 1.34 X | ||||
| Book Value Per Share | 17.35 X | ||||
| Cash Flow From Operations | 31.71 M | ||||
| Earnings Per Share | 2.79 X | ||||
| Market Capitalization | 507.91 M | ||||
| Total Asset | 515.38 M | ||||
| Retained Earnings | 77.6 M | ||||
About Tekla Life Performance
By examining Tekla Life's fundamental ratios, stakeholders can obtain critical insights into Tekla Life's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Tekla Life is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 729.96 | 648.86 | |
| Return On Tangible Assets | 0.15 | 0.16 | |
| Return On Capital Employed | 0.15 | 0.16 | |
| Return On Assets | 0.15 | 0.16 | |
| Return On Equity | 0.15 | 0.16 |
Things to note about Tekla Life Sciences performance evaluation
Checking the ongoing alerts about Tekla Life for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Tekla Life Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Tekla Life Sciences has a strong financial position based on the latest SEC filings | |
| On 12th of January 2026 Tekla Life paid $ 0.5 per share dividend to its current shareholders | |
| Latest headline from MacroaxisInsider: Acquisition by Reit Todd of 1000 shares of Tekla Life at 13.798 subject to Rule 16b-3 |
- Analyzing Tekla Life's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Tekla Life's stock is overvalued or undervalued compared to its peers.
- Examining Tekla Life's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Tekla Life's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Tekla Life's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Tekla Life's stock. These opinions can provide insight into Tekla Life's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Tekla Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in small area income & poverty estimates. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tekla Life. Market participants price Tekla higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Tekla Life assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth 2.594 | Dividend Share 1.82 | Earnings Share 2.79 | Revenue Per Share | Quarterly Revenue Growth (0.70) |
Tekla Life Sciences's market price often diverges from its book value, the accounting figure shown on Tekla's balance sheet. Smart investors calculate Tekla Life's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since Tekla Life's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Tekla Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tekla Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tekla Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.